<SEC-DOCUMENT>0001576885-23-000023.txt : 20230509
<SEC-HEADER>0001576885-23-000023.hdr.sgml : 20230509
<ACCEPTANCE-DATETIME>20230509070815
ACCESSION NUMBER:		0001576885-23-000023
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		53
CONFORMED PERIOD OF REPORT:	20230509
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230509
DATE AS OF CHANGE:		20230509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acumen Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001576885
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				364108129
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40551
		FILM NUMBER:		23899926

	BUSINESS ADDRESS:	
		STREET 1:		427 PARK ST.
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902
		BUSINESS PHONE:		925-368-8508

	MAIL ADDRESS:	
		STREET 1:		427 PARK ST.
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22902
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>abos-20230509.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:dff8b17c-4c46-4673-87d7-00f4f91431b2,g:071e6620-e0ea-444a-ad38-5eef9bb44471,d:d727753b1fbc43d49dbaf9f7b2bf5a4a--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>abos-20230509</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if75dc1dce0a044dc9205de58d68e56f2_D20230509-20230509" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQ3Mjc3NTNiMWZiYzQzZDQ5ZGJhZjlmN2IyYmY1YTRhL3NlYzpkNzI3NzUzYjFmYmM0M2Q0OWRiYWY5ZjdiMmJmNWE0YV80L2ZyYWc6ZWZjMmJiYjkzZTIxNDJkYzg5NTQ1OGIwNWNmYmIxODQvdGFibGU6YjgwMTQ2YTUwNzk3NDhlOWE1ZDkzMTg4MDA0YzdkNDIvdGFibGVyYW5nZTpiODAxNDZhNTA3OTc0OGU5YTVkOTMxODgwMDRjN2Q0Ml8wLTEtMS0xLTIwOTI2_e8b020cf-fa3c-41e8-bddb-4ad955d37a9e">0001576885</ix:nonNumeric><ix:nonNumeric contextRef="if75dc1dce0a044dc9205de58d68e56f2_D20230509-20230509" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmQ3Mjc3NTNiMWZiYzQzZDQ5ZGJhZjlmN2IyYmY1YTRhL3NlYzpkNzI3NzUzYjFmYmM0M2Q0OWRiYWY5ZjdiMmJmNWE0YV80L2ZyYWc6ZWZjMmJiYjkzZTIxNDJkYzg5NTQ1OGIwNWNmYmIxODQvdGFibGU6YjgwMTQ2YTUwNzk3NDhlOWE1ZDkzMTg4MDA0YzdkNDIvdGFibGVyYW5nZTpiODAxNDZhNTA3OTc0OGU5YTVkOTMxODgwMDRjN2Q0Ml8xLTEtMS0xL